Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
While it has always been difficult being an adolescent (teen/teenager), todays adolescents currently face
more challenges than in the past. Even healthy and socially well-adapted teens can have a difficult time
coping during this period of physical and emotional transition in their body and minds. The most prevalent
medico-social issues facing adolescents are pregnancy, substance abuse and eating disorders. This course
is intended to help the dental professional identify and manage adolescent pregnancy issues and their dental
implications.
ADA CERP
The Procter & Gamble Company is designated as an Approved PACE Program Provider
by the Academy of General Dentistry. The formal continuing education programs of this
program provider are accepted by AGD for Fellowship, Mastership, and Membership
Maintenance Credit. Approval does not imply acceptance by a state or provincial board
of dentistry or AGD endorsement. The current term of approval extends from 8/1/2013 to
7/31/2017. Provider ID# 211886
Overview
Besides struggling with physical changes to their bodies, adolescents must deal with emotional,
psychological and social problems at school, home and among peers. Instead of worrying about acne,
finding a date for the prom or making a team, they now face more pressing issues of choosing a career,
acceptance into college and a more competitive job market. Additionally, the issues of cyberbullying
and social acceptance may lead them to coping behaviors resulting in life-threatening and life-changing
concerns with associated dental implications.
The most prevalent medico-social issues facing adolescents are pregnancy, substance abuse and eating
disorders. This course is intended to help the dental professional identify and manage adolescent
pregnancy issues and their dental implications.
Learning Objectives
Upon completion of this course, the dental professional should be able to:
Identify the risk factors and complications linked to adolescent pregnancy.
Identify the physiological changes in the pregnant female.
Discuss oral health care with the pregnant patient.
Understand informed consent as it relates to the pregnant adolescent patient.
Learn the guidelines for minimizing the potential teratogenic effects of drugs and x-rays to the pregnant
patient and during postpartum breastfeeding.
Treat the pregnant patient safely and comfortably.
Course Contents
References
About the Author
Introduction
Background
Physiologic Changes in the Pregnant Female
Oral Health Care during Pregnancy
Legal Considerations for the Adolescent Patient
Recommendations
Dental Radiographs
Restorative Dentistry
Fetal Health Considerations and Dental
Implications
Pharmacologic Considerations
Analgesics
Antibiotic and Antimicrobials
Local Anesthetics
Fluoride
Sedatives and Anxiolytics
Summary Treatment Recommendations
Conclusion
Course Test Preview
Introduction
Background
Recommendations
Dental Radiographs
The two major risks to the developing fetus
caused by excessive exposure to radiation are
development of cancer and mental retardation. It
appears that 10 microsieverts (Sv) of radiation is
the level required for either effect to occur.22 With
proper radiographic techniques and precautions,
the amount of radiation exposure from dental
x rays ranges for bitewing radiographs from 26
Sv (skin dose) 0 Sv (thyroid dose), and for full
mouth series from 90-122 Sv (skin dose) to 117550 Sv (thyroid dose). To put these values in
perspective, background radiation from natural
occurring sources is approximately 3,100 Sv
annually.23 The fetus is most sensitive to the
effects of radiation between the eighth and 15th
weeks after conception, a period of major neuronal
and organ development.24 Proper radiographic
techniques, such as rectangular collimation, lead
shielding (abdominal and thyroid), use of the
fastest available films (E/F speed film or digital),
use of a long cone and avoidance of retakes,
ensure that radiation exposure to the pregnant
patient and fetus is minimized. However, even
with observance of these precautions, the dental
x-ray beam may pass through or near the thyroid
gland. The juvenile thyroid is very sensitive
to radiation induced tumors, both benign and
malignant. In addition, thyroid radiation exposure
during pregnancy is associated with infant low birth
weight. If dental treatment will be deferred until
after delivery, so should dental radiographs.25,26
Patients who are reluctant to accept necessary
radiographs should be explained the risk of
complications is so low it is impossible to measure.
Pharmacologic Considerations
Restorative Dentistry
Elective restorative and periodontal therapies
are best performed during the second trimester.
However, emergency dental treatment for pain
or dental infection should not be delayed during
the first trimester or postponed until after delivery
during the third trimester. When considering
therapeutic agents for local anesthesia, infection,
postoperative pain or sedation, the dental
practitioner should evaluate the risks and benefits
of the treatment to the pregnant patient and the
fetus and discuss such issues with the patient.29
Patients should be explained the risks and benefits
of amalgam fillings and alternative non-mercury
containing restorations during treatment. Evidence
is insufficient to support or refute that mercury
exposure from dental amalgam contributes to
deleterious effects for the fetus. Rubber dam and
high speed suction should be used, especially
during placement or removal of amalgam
restorations to reduce the risk of vapor inhalation.30
Because of the release of bisphenol A (BPA) and
accumulating evidence that BPA and some BPA
derivatives can pose health risks attributable to
their endocrine-disrupting, estrogenic properties,
the use of composite restorations should be
minimized during pregnancy. BPA is detectable in
saliva for up to 3 hours after placement. Immediate
removal of BPA is recommended after placement
by having the patient gargle water for 30 seconds
after placement or rubbing the restoration with
pumice on a cotton ball or in a rotating rubber
dental prophylaxis cup.31
Analgesics
Analgesics are taken for a short period of time,
usually 2 or 3 days. Acetaminophen, with a
pregnancy risk category B, is the safest drug
for management of short-term oral pain during
pregnancy. However, there is a potential for
liver toxicity in higher dosages. As it is an overthe-counter drug and patients may not read the
accompanying directions and precautions, patients
should receive detailed instructions from the
10
11
12
Fluoride
Fluoride is a category C drug. It may be
prescribed for topical use to the pregnant patient
with severe gastric reflux caused by nausea and
vomiting during early pregnancy. The gastric
fluids erode tooth enamel resulting in tooth
sensitivity and increased potential for decay.
Application of topical fluoride to the exposed
dentin may reduce the sensitivity. As topical
fluoride gel may cause nausea, fluoride varnish
application may be better tolerated.
13
Conclusion
14
To receive Continuing Education credit for this course, you must complete the online test. Please go to:
www.dentalcare.com/en-US/dental-education/continuing-education/ce463/ce463-test.aspx
1.
2.
3.
4.
In pregnant females aged 11 years to 15 years medical complications in the mother and
fetus occur ______________ than those aged 20 through 22 years.
a. more frequently
b. less frequently
c. the same
d. at varying frequency
5.
6.
7.
8.
15
9.
10. Studies of the relationship of periodontitis during pregnancy to preterm and low birth
infants have produced ______________.
a. positive correlations
b. negative correlations
c. mixed results
d. positive only if it occurs early in the pregnancy
11. Laws regarding consent by pregnant patients under 18 years of age ______________.
a. vary from state-to-state
b. are consistent from state to state
c. always require parental knowledge of the pregnancy
d. are determined by the Supreme Court
12. The fetus is most sensitive to the effects of radiation during ______________.
a. eight and fifteen weeks after conception
b. the entire first trimester
c. the entire second trimester
d. the entire third trimester
13. The following statement is true about the placement of composites during pregnancy.
a. It is much safer than placement of amalgam.
b. The release of BPA in composite restorations can pose health risks during pregnancy.
c. The placement of composite restorations should be minimized during pregnancy.
d. B & C
14. The greatest risk from teratogenic drugs to the fetus ______________.
a. is from three to eight weeks after conception
b. during the second trimester
c. during the third trimester
d. is immediate postpartum
15. A strategy to minimize the concentration of drugs in a mothers milk during breast feeding
is ______________.
a. avoid prescribing sustained release drugs
b. take medications immediately after breastfeeding
c. pump and save breast milk before taking medication for later use
d. All the above.
16. Pregnancy Risk Classification (PRC) C drugs ______________.
a. can be safely used during pregnancy
b. may be used with caution
c. should be avoided
d. may be used during breast feeding
16
17
References
1. Dorland WAN. Dorlands Illustrated Medical Dictionary. Philadelphia, PA. Saunders/Elsevier, 2012.
2. WHO. Health for the worlds adolescents. A second chance in the second decade. Geneva. World
Health Organization, 2014. Accessed February 16, 2015.
3. Martin JA, Hamilton BE, Osterman MJK, et al. Births: Final data for 2013. National vital statistics reports.
Vol. 64(1). Hyattsville, MD. National Center for Health Statistics, 2015. Accessed February 16, 2015.
4. Kost K, Henshaw S. U.S. teenage pregnancies, births and abortions, 2010: National and state trends
by age, race and ethnicity. New York. Guttmacher Institute, 2014. Accessed February 16, 2015.
5. United Nations Statistics Division. Demographic Yearbook 2009-2010: Live births by age of mother
and sex of child, general and age-specific fertility rates: latest available year 2000-2009, and 2010.
New York, NY. United Nations, 2014. Accessed February 16, 2015.
6. Haffner DW. Facing Facts: Sexual Health for Americas Adolescents. The Report of the National
Commission on Adolescent Sexual Health. New York, NY. Sexuality Information and Education
Council of the United States (SIECUS), 1995. Accessed February 16, 2015.
7. Klein JD, American Academy of Pediatrics Committee on Adolescence. Adolescent pregnancy: current
trends and issues. Pediatrics. 2005 Jul;116(1):281-6.
8. Kirby D. Emerging Answers: Research findings on programs to reduce teen pregnancy (summary).
Washington, DC. National Campaign to Prevent Teenage Pregnancy, 2001. Accessed February 16,
2015.
9. Rudlin K. Teen pregnancy risk factors. Womens Health Queensland Wide, Southeastern Idaho
District Health Department. Accessed February 16, 2015.
10. Bradley T, Cupples ME, Irvine H. A case control study of a deprivation triangle: teenage motherhood,
poor educational achievement and unemployment. Int J Adolesc Med Health. 2002 Apr-Jun;14(2):117-23.
11. Forrest JD. Timing of reproductive life stages. Obstet Gynecol. 1993;82(1):105-11.
12. Healthy People. 2020 Topics and objectives: Tobacco use. Washington DC. US Department of Health
and Human Services. Accessed February 16, 2015.
13. Kurien S, Kattimani VS, Sriram RR, et al. Management of pregnant patient in dentistry. J Int Oral
Health. 2013 Feb;5(1):88-97.
14. Charles JM. Dental care in children with developmental disabilities: attention deficit disorder,
intellectual disabilities, and autism. J Dent Child (Chic). 2010 May-Aug;77(2):84-91.
15. Hilgers KK, Douglass J, Mathieu GP. Adolescent pregnancy: a review of dental treatment guidelines.
Pediatr Dent. 2003 Sep-Oct;25(5):459-67.
16. US Census Bureau. Disability Characteristics. 2010 American Community Survey 1-Year Estimates,
S1810. Accessed March 19, 2015.
17. Gaffield ML, Gilbert BJ, Malvitz DM, et al. Oral health during pregnancy: an analysis of information
collected by the pregnancy risk assessment monitoring system. J Am Dent Assoc. 2001 Jul;
132(7):1009-16.
18. Morgan MA, Cragan JD, Goldenberg RL, et al. Management of prescription and nonprescription drug
use during pregnancy. J Matern Fetal Neonatal Med. 2010 Aug;23(8):813-9.
19. American Academy of Pediatric Dentistry. 2014-15 Definitions, Oral Health Policies, and Clinical
Guidelines. Clinical Practice Guidelines. Guideline on informed consent. Reference Manual.
Vol. 36(6):310-312. Accessed February 16, 2015.
20. American Academy of Pediatric Dentistry. 2014-15 Definitions, Oral Health Policies, and Clinical
Guidelines. Clinical Practice Guidelines. Guideline on oral health care for the pregnant adolescent.
Reference Manual. Vol. 36(6):154-160. Accessed February 16, 2015.
21. American Academy of Pediatric Dentistry reference manual 2011-2012. Pediatr Dent. 2011;33
(6 Reference Manual):1-349.
22. Abbott P. Are dental radiographs safe? Aust Dent J. 2000 Sep;45(3):208-13.
23. Ludlow JB, Davies-Ludlow LE, White SC. Patient risk related to common dental radiographic
examinations: The impact of 2007 International Commission on Radiological Protection
recommendations regarding dose calculation. J Am Dent Assoc. 2008 Sep;139(9):1237-43.
18
24. White SC. 1992 assessment of radiation risk from dental radiography. Dentomaxillofac Radiol. 1992
Aug;21(3):118-26.
25. National Council on Radiation Protection and Measurements. Radiation protection in dentistry; report
no. 145. Bethesda, MD. NRCP Publications, 2003. Accessed February 16, 2015.
26. Berthold M. JAMA dental radiography study bolsters ADA recommendations. J Am Dent Assoc. 2004
Jun;135(6):724. Accessed February 16, 2015.
27. Maillie HD, Gilda JE. Radiation-induced cancer risk in radiographic cephalometry. Oral Surg Oral
Med Oral Pathol. 1993 May;75(5):631-7.
28. Nowak AJ, Casamassimo PS. The handbook of pediatric dentistry. 4th Ed. Chicago. The American
Academy of Pediatric Dentistry, 2011.
29. California Dental Association Foundation. Oral health during pregnancy and early childhood:
Evidence-based guidelines for health professionals. Perinatal Oral Health Practice Guidelines, Feb
2010. Accessed February 16, 2015.
30. US Food and Drug Administration. White Paper: FDA update/review of potential adverse health risks
associated with exposure to mercury in dental amalgam, Jul 2009. Accessed February 16, 2015.
31. Fleisch AF, Sheffield PE, Chinn C, et al. Bisphenol A and related compounds in dental materials.
Pediatrics. 2010 Oct;126(4):760-8.
32. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol.
2004 Aug;191(2):398-407.
33. Donaldson M, Goodchild JH. Pregnancy, breast-feeding and drugs used in dentistry. J Am Dent
Assoc. 2012 Aug;143(8):858-71.
34. Centers for Disease Control and Prevention. Breastfeeding among U.S. children born 2001-2011, CDC
National Immunization Survey. Page last updated November 18, 2014. Accessed February 19, 2015.
35. American Academy of Pediatrics. AAP issues policy statement on the transfer of drugs and other
chemicals into human milk. Am Fam Physician. 1994 May 1;49(6):1527-9.
36. American Academy of Pediatric Dentistry. Guideline on Fluoride Therapy. Clinical Guidelines.
Reference Manual. 2014;36(6)171-74. Accessed March 19, 2015.
37. Giglio JA, Lanni SM, Laskin DM, et al. Oral health care for the pregnant patient. J Can Dent Assoc.
2009 Feb;75(1):43-8.
19